• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Hypertension and Dementia: Epidemiological and Experimental
Hypertension and Dementia: Epidemiological and Experimental

Central Nervous System Neurodegeneration and Tinnitus
Central Nervous System Neurodegeneration and Tinnitus

Full Text  - The Journal of International Advanced Otology
Full Text - The Journal of International Advanced Otology

Neuroscience Information Framework Standard Ontologies
Neuroscience Information Framework Standard Ontologies

Vestibular Disease: Diseases Causing Vestibular Signs
Vestibular Disease: Diseases Causing Vestibular Signs

The non-motor complications in Parkinson`s disease
The non-motor complications in Parkinson`s disease

Poster
Poster

dsm 5 major changes from dsm iv - Stanford Geriatric Education
dsm 5 major changes from dsm iv - Stanford Geriatric Education

Materials and Methods
Materials and Methods

... 2002). Deficit in different neurotransmitters are shown to be increased with progress of disease pathology (Selkoe 1998; Hardy and Selkoe 2002). Analysis in postmortem tissue has suggested 25–35% loss in synapses in AD brain (DeFelipe and Farinas 1992). Metabolic analysis using Positron Emission Tom ...
An Introduction to Lewy Body Dementia
An Introduction to Lewy Body Dementia

Treatment for Progressive Hearing Loss Due to Paget`s Disease of
Treatment for Progressive Hearing Loss Due to Paget`s Disease of

Protocol S1.
Protocol S1.

IS IT DEPRESSION, IS IT DEMENTIA OR BOTH?
IS IT DEPRESSION, IS IT DEMENTIA OR BOTH?

Dynamic relationships between age, beta
Dynamic relationships between age, beta

FINAL-FTDMulticenterStudy_R - ORBi
FINAL-FTDMulticenterStudy_R - ORBi

Dementia and Hearing Loss
Dementia and Hearing Loss

Autoimmune Inner Ear Disease January 2000
Autoimmune Inner Ear Disease January 2000

Donepezil hydrochloride (Aricept)
Donepezil hydrochloride (Aricept)

Sundowning syndrome in aging and dementia
Sundowning syndrome in aging and dementia

The role of metabotropic glutamate receptors in Alzheimer`s disease
The role of metabotropic glutamate receptors in Alzheimer`s disease

Doberman Headbobbing Syndrome
Doberman Headbobbing Syndrome

Rivastigmine Patch
Rivastigmine Patch

Epidemiology of IBD
Epidemiology of IBD

Hypochondriasis - Monique ppt
Hypochondriasis - Monique ppt

Neuro Exam - Teddie Joe Snodgrass
Neuro Exam - Teddie Joe Snodgrass

< 1 ... 6 7 8 9 10 11 12 13 14 ... 47 >

Alzheimer's disease



Alzheimer's disease (AD), also known as Alzheimer disease, or just Alzheimer's, accounts for 60% to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts slowly and gets worse over time. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD. There are no medications or supplements that decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programs are beneficial with respect to activities of daily living and can potentially improve outcomes. Treatment of behavioral problems or psychosis due to dementia with antipsychotics is common but not usually recommended due to there often being little benefit and an increased risk of early death.In 2010, there were between 21 and 35 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2010, dementia resulted in about 486,000 deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report